Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation.

Abstract

Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ transplantation, resulting in significant morbidity, graft loss, and adverse outcomes. Management of CMV varies considerably among transplant centers but has been become more standardized by publication of consensus guidelines by the Infectious Diseases Section of The Transplantation Society. An international panel of experts was reconvened in October 2012 to revise and expand evidence and expert opinion-based consensus guidelines on CMV management, including diagnostics, immunology, prevention, treatment, drug resistance, and pediatric issues. The following report summarizes the recommendations.

• Authors: Camille N Kotton, Deepali Kumar, Angela M Caliendo, Anders Asberg, Sunwen Chou, Lara Danziger-Isakov, Atul Humar, Transplantation Society International CMV Consensus Group
• Journal: Transplantation (Transplantation) Vol. 96 Issue 4 Pg. 333-60 (Aug 27 2013) ISSN: 1534-6080 [Electronic] United States
• PMID: 23896556 (Publication Type: Consensus Development Conference, Journal Article, Practice Guideline)

Chemical References

• Viral Vaccines

Topics

• Child
• Cytomegalovirus Infections (drug therapy, etiology, prevention & control)
• Drug Resistance, Viral
• Humans
• International Agencies
• Monitoring, Immunologic
• Organ Transplantation (adverse effects)
• Preoperative Care
• Societies, Medical
• Tissue Donors
• Viral Vaccines (therapeutic use)